Chemical Genetics: Budding Yeast as a Platform for Drug Discovery and Mapping of Genetic Pathways
Open Access
Abstract
The budding yeast Saccharomyces cerevisiae is a widely used model organism, and yeast genetic methods are powerful tools for discovery of novel functions of genes. Recent advancements in chemical-genetics and chemical-genomics have opened new avenues for development of clinically relevant drug treatments. Systematic mapping of genetic networks by high-throughput chemical-genetic screens have given extensive insight in connections between genetic pathways. Here, I review some of the recent developments in chemical-genetic techniques in budding yeast.Keywords
This publication has 79 references indexed in Scilit:
- Sequential Application of Anticancer Drugs Enhances Cell Death by Rewiring Apoptotic Signaling NetworksCell, 2012
- Evolutionary and Biochemical Aspects of Chemical Stress Resistance in Saccharomyces cerevisiaeFrontiers in Genetics, 2012
- A chemical-genetic screen to unravel the genetic network of CDC28/CDK1 links ubiquitin and Rad6–Bre1 to cell cycle progressionProceedings of the National Academy of Sciences, 2011
- An overview of Cdk1-controlled targets and processesCell Division, 2010
- Progression through the RNA Polymerase II CTD CycleMolecular Cell, 2009
- Changing perspectives in yeast research nearly a decade after the genome sequenceGenome Research, 2005
- Principles for the Buffering of Genetic VariationScience, 2001
- Genomic profiling of drug sensitivities via induced haploinsufficiencyNature Genetics, 1999
- Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progressionCell, 1993
- Targets for Cell Cycle Arrest by the Immunosuppressant Rapamycin in YeastScience, 1991